EN DE
Watch Hartford Great Health Corp for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Hartford Great Health Corp (HFUS) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Hartford Great Health Corp stock $0.54, price $3.00, that is 82.0% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Communication Services US

HG Hartford Great Health Corp logo Thin data Nov 14, 2026

Hartford Great Health Corp

HFUS · US

Far too expensive (fair value 82% below the price), but solid company.

Get notified free when this changes
Highly profitable · 56.1% net margin (TTM) 
Quality 55/100 
Mixed Growth (revenue 5y +83.3 %/yr in USD) 
Mixed vs. peers (5/11) 
Wide moat 84/100 · thin data
Costs 60 times its yearly profit. 
Fair value $0.5400 · Strongly overvalued 
High debt 
Negative free cash flow 
Thin data 
Extreme value⚠ Thinly traded⚠ Small free float
Watch Hartford Great Health Corp for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$14.60 $0.0800 Fair Value $0.5400 Apr 2012 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range $0.0800 – $14.60 · fair‑value band $0.3400 – $0.7400 · the $3.00 price screens above the $0.5400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow Hartford Great Health in your weekly email

Every Wednesday you see whether Hartford Great Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Hartford Creative Group, Inc. provides marketing solutions in China. The company offers vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps.

Show moreShow less

The company provides placing ad products on TikTok, Toutiao, Kwai, RED, WeChat, Baidu and other third-party affiliated websites and mobile applications.

It serves advertising buyers, comprising small- and medium-sized companies, large advertising holding companies, independent advertising agencies, and mid-market advertising service organizations.

The company was formerly known as Hartford Great Health Corp. and changed its name to Hartford Creative Group, Inc. in May 2024. Hartford Creative Group, Inc. was incorporated in 2008 and is based in Rosemead, California.

Stock analysis

Hartford Great Health Corp (HFUS) currently trades at $3.00, while our model-based Fair Value estimate is $0.5400, 82% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $2.04 per share, and 0 of the 15 models we run sit above the $3.00 price.

Bear case: the Economic Profit group reads lowest at $0.2550, and 15 of the 15 models stay below the price. Data coverage for this calculation is low.

Scenario range: $0.3400 (bear) to $0.7400 (bull), the price of $3.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 55/100 (solid quality), in the Communication Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Hartford Great Health Corp reported revenue of $2.0M in FY2025 versus $553K in FY2021, a compound +38.5%/yr. Reported net income was $1.1M in FY2025.

Key figures

Market cap $75.1M Micro · P/E ratio 60.0 · P/S ratio 31.1 · EPS (TTM) $0.0500 · Net margin 56.1% · Return on assets (EBIT) −7.3% (5-year average) · Operating margin 79.6% · Revenue (TTM) $2.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 84 out of 100 (low confidence).

What moves the price

The share trades about 44% below its 52-week high and 50% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Communication Services peers we cover trades at 9% fair-value upside, at −82%, HFUS screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely ($0.0100 to $2.08). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear $0.3400 Fair Value $0.5400 Bull $0.7400
Price $3.00 · Downside -82.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($0.0500 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV $0.3100 $0.3500 $0.3900 74
ROIC Compounder $0.3400 $0.4400 $0.5500 70
Owner Earnings $0.2500 $0.5400 $1.07 69
All 15 models by family
DCF Models
Owner Earnings $0.2500 $0.5400 $1.07 69
Earnings-Based
Graham-Dodd $0.3000 $2.08 $2.92 61
Lynch FV $1.08 $1.54 $2.00 59
PEG = 1.0 $1.08 $1.54 $2.00 55
EPV $0.3100 $0.3500 $0.3900 74
Multiples
P/E Multiple $0.7200 $0.9700 $1.21 63
P/S Multiple $0.0700 $0.1000 $0.1200 58
P/B Multiple $0.0400 $0.0500 $0.0600 55
EV/EBIT $0.6600 $0.8800 $1.10 66
EV/EBITDA $0.4400 $0.5900 $0.7400 67
EV/Revenue $0.0700 $0.1000 $0.1300 53
Asset-Based
NCAV (Graham) $0.0100 $0.0100 $0.0100 55
Economic Profit
Residual Income $0.0400 $0.0700 $0.1900 58
ROIC Compounder $0.3400 $0.4400 $0.5500 70
Growth Earnings
Growth-Adj P/E $1.43 $2.04 $2.65 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 55/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 71
How much profit the company makes from its sales and capital
Quality Growth 29
Are margins and returns getting better?
Cashflow 14
Do the profits arrive as real cash?
Financial strength 41
Debt, balance sheet and risk of trouble
Investment 62
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 34
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 59
Distance to the 52-week high, does not count
New shares 90
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 13, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 51/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+45.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+53.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+83.3%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+81.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,902.9% (2020) → 60.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: rate outside our plausibility band
not computed

HFUS screens overvalued: fair value 82% below the price. Compare with AppLovin Corporation →

Compare Hartford Great Health Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Advertising Agencies · 194 stocks

Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 55 · Above median
Fair Value upside −82.0% · Bottom 25%
Profitability
Return on assets 15.9% · Top 25%
Net margin (12 months) 56.1% · Top 25%
Operating margin (12 months) 79.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 196.3% · Top 25%
Balance sheet
Debt / equity 2.20× · Highest 25%

Valuation Multiplesvs Advertising Agencies median · lower = cheaper

P/E (12 months) 60.0× · Priciest 25%
P/S (12 months) 31.15× · Priciest 25%
EV/EBITDA 46.0× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 32
FUTURE (revenue growth)100 · sector 19
PAST (return on equity)0 · sector 6
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 54

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Advertising Agencies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
The Trade Desk, Inc TTD $15.68 $47.04 +200% vs HFUS
Publicis Groupe S.A PUB €105.70 €145.63 +38% vs HFUS
Omnicom Group OMC $87.98 $113.06 +29% vs HFUS
Magnite, Inc MGNI $29.29 $32.13 +10% vs HFUS
AppLovin Corporation APP $409.10 $445.25 +9% vs HFUS
Focus Media Information Technology Co 002027 ¥5.49 ¥5.86 +7% vs HFUS
JCDecaux SE DEC €28.14 €20.99 −25% vs HFUS
Leo Group 002131 ¥4.13 ¥2.07 −50% vs HFUS
Easy Click Worldwide Network Technology Co 301171 ¥32.77 ¥11.05 −66% vs HFUS
Stagwell Inc STGW $11.27 $2.62 −77% vs HFUS

Explore undervalued stocks

More undervalued Communication Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Hartford Great Health Corp: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Hartford Great Health Corp Fair Value". https://www.fairvalue-calculator.com/stock/HFUS

Frequently asked questions

Is Hartford Great Health Corp (HFUS) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of $0.5400 versus a price of $3.00, about 82% lower (overvalued).
What is the fair value of HFUS?
Our model-based fair value for Hartford Great Health Corp is $0.5400 (as of Nov 14, 2026), built from audited fundamentals. The current price: $3.00.
What is the quality score of HFUS?
Hartford Great Health Corp has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hartford Great Health Corp (HFUS)?
Our model-based price target is the fair value of $0.5400 (as of Nov 14, 2026) from 15 valuation models. Cautious scenario $0.3400, optimistic scenario $0.7400. It is a calculation from audited fundamentals, not an analyst target.
What is the Hartford Great Health Corp stock forecast for 2026?
Our models put fair value at $0.5400, about 82% lower versus a price of $3.00 (overvalued). Cautious scenario $0.3400, optimistic scenario $0.7400. The calculation is refreshed regularly with new filings.
What is the revenue of Hartford Great Health Corp (HFUS)?
Hartford Great Health Corp reported trailing-twelve-month revenue of about $2.4M (latest available figure, as of Nov 14, 2026).
What is the intrinsic value of Hartford Great Health Corp (HFUS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hartford Great Health Corp it is $0.5400 per share (as of Nov 14, 2026), against a price of $3.00. It is the blended result of 15 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Hartford Great Health Corp stock overvalued or undervalued in 2026?
As of Nov 14, 2026, HFUS trades above its calculated fair value: price $3.00, fair value $0.5400, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HFUS?
No. The price is what the market pays today ($3.00); the fair value is what the company's own numbers justify ($0.5400). For Hartford Great Health Corp the two are $2.46 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hartford Great Health Corp worth?
The market values Hartford Great Health Corp at about $75.1M (market capitalisation, as of Nov 14, 2026). Per share that is $3.00; our models calculate a fair value of $0.5400 per share.
What do the bullish and bearish scenarios say about HFUS?
Our models span a range for Hartford Great Health Corp: cautious scenario $0.3400, base $0.5400, optimistic $0.7400 per share (as of Nov 14, 2026, price $3.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HFUS?
Hartford Great Health Corp trades at a price-to-earnings ratio of 60.0 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.5400 is built from several models across several years. Other multiples: P/S 31.1, EV/EBITDA 46.0.
How solid is the balance sheet of Hartford Great Health Corp (HFUS)?
Balance-sheet figures for Hartford Great Health Corp (as of Nov 14, 2026): debt of 2.20 per unit of equity. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is HFUS from its 52-week high?
Hartford Great Health Corp trades at $3.00, about 44% below its 52-week high of $5.36 and 50% above the low of $2.00 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5400 is for.
Which stocks are comparable to Hartford Great Health Corp?
From the same area (Communication Services) we also value AppLovin Corporation, Publicis Groupe S.A, Omnicom Group, Focus Media Information Technology Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hartford Great Health Corp stock attractive at the current price?
The data as of Nov 14, 2026: price $3.00, calculated fair value $0.5400 (−82%), Quality Score 55/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HFUS calculated?
We run Hartford Great Health Corp through 15 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $0.5400 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1% above its aggregate fair value. Hartford Great Health Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hartford Great Health Corp (HFUS)?
The closing price on Nov 13, 2026 was $3.00. Our model-based fair value is $0.5400, about 82% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hartford Great Health Corp right now?
The price sits above even our optimistic bull case ($0.7400). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($0.3400 to $0.7400) leaves room in how you read the outcome.

Key figures of Hartford Great Health Corp

How large is the market capitalisation of Hartford Great Health Corp (HFUS)?
The market capitalisation of Hartford Great Health Corp is $75.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hartford Great Health Corp (HFUS)?
The price-to-sales ratio of Hartford Great Health Corp is 31.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hartford Great Health Corp (HFUS)?
Earnings per share at Hartford Great Health Corp are $0.0500 (price ÷ EPS = P/E 60.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Hartford Great Health Corp (HFUS)?
The net margin of Hartford Great Health Corp is 56.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Hartford Great Health Corp (HFUS)?
On an EBIT basis the return on assets of Hartford Great Health Corp is −7.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hartford Great Health Corp (HFUS)?
The operating margin of Hartford Great Health Corp is 79.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hartford Great Health Corp (HFUS)?
Revenue at Hartford Great Health Corp is growing 196% versus a year earlier (3y avg +53.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hartford Great Health Corp (HFUS)?
Earnings per share at Hartford Great Health Corp are growing 513% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Hartford Great Health Corp (HFUS) generate?
The free cash flow of Hartford Great Health Corp is −$13.4K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Hartford Great Health Corp (HFUS) hold?
Hartford Great Health Corp holds more cash than debt, $51.6K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Hartford Great Health Corp in the live analysis

One click puts Hartford Great Health Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.